Valorization of Egyptian Food Byproducts in the Development of Biologically Active Nutraceuticals.

dc.AffiliationOctober University for modern sciences and Arts (MSA)
dc.contributor.authorAbdel-Sattar, Essam
dc.contributor.authorAmer, Reham I.
dc.contributor.authorBagrel, Denyse
dc.contributor.authorEl Mansourai, Latifa
dc.contributor.authorPhilippot, Stéphanie
dc.contributor.authorDarwish El-Tanbouly, Nebal
dc.contributor.authorEvain-Bana, Emilie
dc.contributor.authorBoukhira, Smahane
dc.contributor.authorAbou-Hussein, Dina R.
dc.contributor.authorBousta, Dalila
dc.contributor.authorTzanova, Tzvetomira
dc.contributor.authorSalah El Dine, Riham
dc.date.accessioned2019-12-16T16:37:47Z
dc.date.available2019-12-16T16:37:47Z
dc.date.issued2018
dc.descriptionMSA Google Scholar
dc.description.abstractThis study was aimed to maximize the benefits of the use of by-products (oil cake) of olive fruits and black seeds after extraction of their fixed oils, rather than their use as animals feed or landfilling or composting. The cake of both seeds was assessed by HPLC for their main bioactive marker compounds (thymoquinone for black seed and oleuropein for olive fruit), to choose the best method for extraction, determination of phenolic contents and in vitro antioxidant activity (DPPH and reducing powers, FRAP assays). Both by-products were also assessed for their cytotoxicity against four human breast cell lines, three of them are cancerous (MCF7, MDA-MB-213, Vcr-R), and a non-cancerous one (epithelial type) but immortalized by telomerase (hTERT-HME), in addition to a human hepatoma cell line (HepG2). Also, both wastes were subjected for in-vitro CDC25s phosphatase inhibition assay on three isoforms (A-C) and for in-vivo immunomodulatory effects. In conclusion, the results of this study showed the interest of cumulating different biological approaches exploring various physiological mechanisms and showed the utility of these extracts in different fields, the first being used as a cytoprotective agent, and the second one being promising as an anticancer agent.en_US
dc.identifier.citationLeouifoudi I, Mbarki M, Tilaoui M, Amechrouq A, Rakib EM, Mouse HA and Zyad A: Study of the in-vitro anticancer activity of Moroccan phenolic olive cake extracts. Journal of Pharmacognosy and Phytochemistry 2014; 2(6): 154-65. Alu’datt MH, Alli I, Ereifej K, Alhamad M, Al-Tawaha AR and Rababah T: Optimisation, characterization and quantification of phenolic compounds in the olive cake. Food Chemistry 2010; 123(1): 117-22. Ramos P, Santos SA, Guerra ÂR, Guerreiro O, Felício L, Jerónimo E, Silvestre AJ, Neto CP and Duarte M: Valorization of olive mill residues: Antioxidant and breast cancer antiproliferative activities of hydroxytyrosol-rich extracts derived from olive oil by-products. Industrial Crops and Products 2013; 46: 359-68. Hashish S and El-Samee LA: Effects of Feeding Olive Cake and Barley Radicle as fiber sources on lipids, cholesterol and fatty acids in Hen Eggs. In: Proceedings of the 15th European Symposium on poultry nutrition, Balatonfüred, Hungary, 25-29 September 2005; World's Poultry Science Association (WPSA) 2005; 628-30. Mohamed SS, Mohamed SR, Abou-Arab AA, Naguib KM, Helmy MH and Owiss NA: Comparison study on the native olive waste extract and its nano-particles effect on oxidative stress induced by aflatoxin B1 in rat brain. Int J Curr Microbiol App Sci 2014; 3(4): 141-52. Mansour RS, Nasser, AK and Abo NY: The Effect of different Nigella sativa seed (cake) concentrations on leukocytes counts and some serum immunological parameters in calves. Tikrit Journal of Pure Science 2013; 18: 31-35. Michel CG, El-Sayed NS, Moustafa SF, Ezzat SM, Nesseem DI and El-Alfy TS: Phytochemical and biological investigation of the extracts of Nigella sativa seed waste. Drug testing and analysis 2011; 3(4): 245-54. Ali B and Blunden G: Pharmacological and toxicological properties of Nigella sativa. Phytotherapy Research 2003; 17(4): 299-05. Al-Ali A, Alkhawajah AA, Randhawa MA and Shaikh NA: Oral and intraperitoneal LD50 of thymoquinone, an active principle of Nigella sativa, in mice and rats. J Ayub Med Coll Abbottabad 2008; 20(2): 25-27. Huat BTK and Swamy SMK: Intracellular glutathione depletion and reactive oxygen species generation are important in α-hederin-induced apoptosis of P388 cells. Molecular and Cellular Biochemistry 2003; 245(1-2): 127-39. Suárez B, Álvarez ÁL, García YD, del Barrio G, Lobo AP and Parra F: Phenolic profiles, antioxidant activity and in-vitro antiviral properties of apple pomace. Food Chemistry 2010; 120(1): 339-42. Molyneux P: The use of the stable free radical diphenylpicrylhydrazyl (DPPH) for estimating antioxidant activity. Songklanakarin J Sci Technol 2004; 26(2): 211-19. Benzie IF and Strain J: The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: the FRAP assay. Analytical Biochemistry 1996; 239(1): 70-76. Soule H, Vazquez J, Long A, Albert S and Brennan M: A human cell line from a pleural effusion derived from breast carcinoma. Journal of the National Cancer Institute 1973; 51(5): 1409-16. Whelan RD, Waring CJ, Wolf CR, Hayes JD, Hosking LK and Hill BT: Over‐expression of P-glycoprotein and glutathione S-transferase PI in MCF-7 cells selected for vincristine resistance in-vitro. International Journal of Cancer 1992; 52(2): 241-46. Cailleau R, Young R, Olive M and Reeves W: Breast tumor cell lines from pleural effusions. Journal of the National Cancer Institute 1974; 53(3): 661-74. Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of Immunological Methods 1983; 65(1-2): 55-63. Boutros R, Lobjois V and Ducommun B: CDC25 phosphatases in cancer cells: key players? Good targets? Nature Reviews Cancer 2007; 7(7): 495-07. Boutros R, Dozier C and Ducommun B: The when and where of CDC25 phosphatases. Current Opinion in Cell Biology 2006; 18(2): 185-91. Bana E, Sibille E, Valente S, Cerella C, Chaimbault P, Kirsch G, Dicato M, Diederich M and Bagrel D: A novel coumarin-quinone derivative SV37 inhibits CDC25 phosphatases, impairs proliferation, and induces cell death. Molecular Carcinogenesis 2015; 54(3): 229-41. Brault L, Denancé M, Banaszak E, El Maadidi S, Battaglia E, Bagrel D and Samadi M: Synthesis and biological evaluation of dialkylsubstituted maleic anhydrides as novel inhibitors of Cdc25 dual specificity phosphatases. European Journal of Medicinal Chemistry 2007; 42(2): 243-47. Valente S, Bana E, Viry E, Bagrel D and Kirsch G: Synthesis and biological evaluation of novel coumarin-based inhibitors of Cdc25 phosphatases. Bioorganic and Medicinal Chemistry Letters 2010; 20(19): 5827-30. Viry E, Anwar A, Kirsch G, Jacob C, Diederich M and Bagrel D: Antiproliferative effect of natural tetrasulfides in human breast cancer cells is mediated through the inhibition of the cell division cycle 25 phosphatases. International Journal of Oncology 2011; 38(4): 1103-11. Brault L and Bagrel D: Activity of novel Cdc25 inhibitors and preliminary evaluation of their potentiation of chemotherapeutic drugs in human breast cancer cells. Life Sciences 2008; 82(5): 315-23. Reed LJ and Muench H: A simple method of estimating fifty per cent endpoints. American Journal of Epidemiology 1938; 27(3): 493-97. Frankel E, Bakhouche A, Lozano-Sánchez Js, Segura-Carretero A and Fernández-Gutiérrez A: Lita erature review on prothe duction process to obtain extra virgin olive oil enriched in bioactive compounds. Potential use of byproducts as alternative sources of polyphenols. Journal of Agricultural and Food Chemistry 2013; 61(22): 5179-88. Rafehi H, Ververis K and Karagiannis TC: Mechanisms of action of phenolic compounds in olive. Journal of Dietary Supplements 201; 9(2): 96-09. Visioli F: Olive oil phenolics: Where do we stand? Where should we go? Journal of the Science of Food and Agriculture 2012; 92(10): 2017-19. Pazos M, Alonso A, Fernández-Bolaños J, Torres JL and Medina I: Physicochemical properties of natural phenolics from grapes and olive oil by-products and their antioxidant activity in frozen horse mackerel fillets. Journal of Agricultural and Food Chemistry 2006; 54(2): 366-73. Meziti A, Meziti H, Boudiaf K, Mustapha B and Bouriche H: Polyphenolic profile and antioxidant activities of Nigella sativa seed extract in-vitro and in-vivo. World Academy of Science, Engineering and Technology 2012; 64(6): 24-32. Ahmad A, Husain A, Mujeeb M, Khan SA, Najmi AK, Siddique NA, Damanhouri ZA and Anwar F: A review on the therapeutic potential of Nigella sativa: A miracle herb. Asian Pacific Journal of Tropical Biomedicine 2013; 3(5): 337-52. Hasani-Ranjbar S, Larijani B and Abdollahi M: A systematic review of the potential herbal sources of future drugs effective in oxidant-related diseases. Inflammation and Allergy-Drug Targets (Formerly Current Drug Targets -Inflammation and Allergy) 2009; 8(1): 2-10. Dilshad A, Abulkhair O, Nemenqani D and Tamimi W: Antiproliferative properties of methanolic extract of Nigella sativa against the MDA-MB-231 cancer cell line. Asian Pacific Journal of Cancer Prevention 2012; 13(11): 5839-42. Neha R, Vali V, Gunaseelan V and Perinbam K: Antioxidant and Antiproliferative Activity of the Methanolic Extract from Nigella sativa Asian Journal of Biological Sciences 2014; 7(3): 122-30. Kim CJ and Cho SK: Pharmacological activities of flavonoids (III) structure-activity relationships of flavonoids in immunosuppression. Archives of Pharmacal Research 1991; 14(2): 147-59. Huang RY, Yu YL, Cheng WC, Ou-Yang CN, Fu E and Chu CL: Immunosuppressive effect of quercetin on dendritic cell activation and function. The Journal of Immunology 2010; 184(12): 6815-21.en_US
dc.identifier.doihttps://doi.org/
dc.identifier.issn2394-5583
dc.identifier.otherhttps://doi.org/
dc.identifier.urihttps://cutt.ly/yrqvIS4
dc.language.isoen_USen_US
dc.publisherIJPen_US
dc.relation.ispartofseriesINTERNATIONAL JOURNAL OF PHARMACOGNOSY;Sr No: 4 Page No: 144-157
dc.subjectImmunomodulatoryen_US
dc.subjectCytotoxicity,en_US
dc.subjectCDC25sen_US
dc.subjectBy-productsen_US
dc.subjectNigella sativaen_US
dc.subjectOlea europeaen_US
dc.titleValorization of Egyptian Food Byproducts in the Development of Biologically Active Nutraceuticals.en_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
avatar_scholar_256.png
Size:
6.31 KB
Format:
Portable Network Graphics
Description:
Loading...
Thumbnail Image
Name:
4-Vol.-5-Issue-3-Mar-2018-IJP-RA-356.pdf
Size:
913.79 KB
Format:
Adobe Portable Document Format
Description: